Defunct Company
Total Trials
23
As Lead Sponsor
As Collaborator
0
Total Enrollment
4,284
NCT00422188
Deoxycholic Acid Injection for the Treatment of Superficial Lipomas
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 31, 2007
Completion: Nov 30, 2007
NCT00618722
Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat
Phase: Phase 1/2
Start: Aug 31, 2007
Completion: Oct 31, 2008
NCT00608842
Phase 2 Study for the Treatment of Superficial Lipomas
Phase: Phase 2
Start: Nov 30, 2007
Completion: Jan 31, 2010
NCT00618709
Dose-Escalation Safety and Pharmacokinetic Study of ATX-101
Start: Jan 31, 2008
Completion: Jan 31, 2009
NCT00618618
Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat
Start: Apr 30, 2008
Completion: Dec 31, 2008
NCT00835952
ATX-101 Abdominoplasty
Start: Nov 30, 2008
Completion: Apr 30, 2009
NCT02159729
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Start: Feb 28, 2009
Completion: Dec 31, 2015
NCT01032889
Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study
Start: Dec 31, 2009
Completion: Dec 31, 2010
NCT01305577
Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat
Phase: Phase 3
Start: Dec 31, 2010
Completion: Jan 31, 2012
NCT01319916
Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue
Completion: Jan 31, 2011
NCT01294644
Start: Jan 31, 2011
Completion: Feb 29, 2012
NCT01426373
Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area
Start: Aug 31, 2011
Completion: Jun 30, 2013
NCT01462786
To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101
Start: Oct 31, 2011
Completion: Dec 31, 2011
NCT01542034
Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area
Start: Feb 29, 2012
Completion: Aug 31, 2013
NCT01546142
Start: Mar 31, 2012
NCT01632917
Open-Label Pharmacokinetic Study of Final Formulations of ATX-101
Start: Jun 30, 2012
Completion: Jul 31, 2012
NCT01706679
Evaluation of the Effect of ATX-101 on QT/QTc Intervals
Start: Oct 31, 2012
NCT02007434
Patient Experience Study of Deoxycholic Acid Injection
Start: Dec 31, 2013
Completion: Jun 30, 2014
NCT02163902
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Completion: Aug 31, 2016
NCT02035267
Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat
Start: Jan 31, 2014
Completion: Jun 30, 2015
NCT02123134
Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age
Start: Apr 30, 2014
Completion: Sep 30, 2015
NCT02438813
Condition of Submental Fullness and Treatment Outcomes Registry
Phase: N/A
Start: May 11, 2015
Completion: Nov 10, 2016